Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy

BJU International

Volumn 108, Issue 5, 2011, Pages 687-692

  Sonpavde, Guru ^a,b,c   Khan, Myrna M ^a,b   Svatek, Robert S ^d   Lee, Richard ^e   Novara, Giacomo ^f   Tilki, Derya ^g   Lerner, Seth P ^b   Amiel, Gilad E ^a,b   Skinner, Eila ^h   Karakiewicz, Pierre I ⁱ   Bastian, Patrick J ^g   Kassouf, Wassim ^j   Fritsche, Hans Martin ^k   Izawa, Jonathan I ^l   Ficarra, Vincenzo ^f   Dinney, Colin P ^d   Lotan, Yair ^m   Fradet, Yves ⁿ   Shariat, Shahrokh F ^e  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS ONCOLOGY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e WEILL CORNELL MEDICAL CENTER   (United States)

^f UNIVERSITY OF PADOVA   (Italy)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITÉ DE MONTRÉAL   (Canada)

^j MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^k UNIVERSITY OF REGENSBURG   (Germany)

^l UNIVERSITY OF WESTERN ONTARIO   (Canada)

^m UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁿ UNIVERSITÉ LAVAL   (Canada)

more..

Author keywords

pathological stage T2N0 bladder cancer; prognosis; radical cystectomy; risk stratification

Indexed keywords

AGE; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TRANSITIONAL CELL CARCINOMA;

COHORT STUDIES; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NOMOGRAMS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 80051981671     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09902.x     Document Type: Article

References (30)

1. Stein JP, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clim Oncol 2001; 19: 666-75 (Pubitemid 32120143)
2. Shariat SF, Palapattu GS, Karakiewicz PI, et al,. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 2007; 51: 137-49; discussion 49- 51
3. Shariat SF, Karakiewicz PI, Palapattu GS, et al,. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414-22; discussion 22 (Pubitemid 44755069)
4. Bochner BH, Kattan MW, Vora KC., Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006; 24: 3967-72 (Pubitemid 46630745)
5. Shariat SF, Karakiewicz PI, Palapattu GS, et al,. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 2006; 12: 6663-76 (Pubitemid 44876834)
6. Karakiewicz PI, Shariat SF, Palapattu GS, et al,. Nomogram for predictin disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 2006; 176: 1354-61; discussion 61- 2
7. Isbarn H, Karakiewicz PI, Shariat SF, et al,. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. J Urol 2009; 182: 459-65; discussion 65
8. Tilki D, Reich O, Karakiewicz PI, et al,. Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome. Eur Urol Jan 2010; 58 (1): 112-7.
9. Herr HW, Faulkner JR, Grossman HB, et al,. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004; 22: 2781-9 (Pubitemid 41079895)
10. Konety BR, Joslyn SA, O'Donnell MA., Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 2003; 169: 946-50 (Pubitemid 36188131)
11. Capitanio U, Suardi N, Shariat SF, et al,. Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int 2009; 103: 1359-62
12. Sobin LH, Fleming ID, TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre Ie Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-4
13. May M, Brookman-Amissah S, Roigas J, et al,. Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications. Eur Urol 2010; 57: 850-8.
14. Lotan Y, Gupta A, Shariat SF, et al,. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005; 23: 6533-9 (Pubitemid 46190245)
15. Shariat SF, Khoddami SM, Saboorian H, et al,. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 2004; 171: 1122-7 (Pubitemid 38327540)
16. Shariat SF, Svatek RS, Tilki D, et al,. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 2010; 105: 1402-12.
17. Rassi A Jr, Rassi A, Little WC, et al,. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006; 355: 799-808 (Pubitemid 44285585)
18. Harrell FE Jr, Lee KL, Mark DB, et al,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87 (Pubitemid 26072233)
19. Volkmer BG, Kuefer R, Bartsch G Jr, et al,. Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer 2005; 104: 2384-91 (Pubitemid 41691559)
20. Grossman HB, Natale RB, Tangen CM, et al,. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-66 (Pubitemid 37025405)
21. Sonpavde G, Goldman BH, Speights VO, et al,. Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy. Cancer 2009; 115: 4104-9
22. Herr HW., Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am 2005; 32: 157-64 (Pubitemid 40603290)
23. Herr HW, Donat SM., Quality control in transurethral resection of bladder tumours. BJU Int 2008; 102: 1242-6
24. Nielsen ME, Shariat SF, Karakiewicz PI, et al,. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 2007; 51: 699-706; discussion 8
25. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH., Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 2006; 107: 2368-74
26. Herr HW., Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003; 61: 105-8 (Pubitemid 36151723)
27. David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM., Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data. Base J Urology 2007; 178: 451-4 (Pubitemid 47030482)
28. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomized controlled trial. International collaboration of trialists. Lancet 1999; 354: 533-40
29. Mitra AP, Pagliarulo V, Yang D, et al,. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol 2009; 27: 3929-37
30. Shariat SF, Karakiewicz PI, Ashfaq R, et al,. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008; 112: 315-25